[
  {
    "rationale": "HPI clearly records increased hunger on glipizide, patient concern about weight gain, resolution of lisinopril-related cough, and new intermittent ankle swelling after starting losartan.",
    "satisfaction": 90.0,
    "score": 18.0
  },
  {
    "rationale": "Assessment links symptoms to medications and advises monitoring, but stops short of asserting causality or outlining concrete alternatives, dose changes, or time-bound follow-up.",
    "satisfaction": 60.0,
    "score": 15.0
  },
  {
    "rationale": "Provides basic education to monitor weight, follow meal plan, check glucose, and report swelling, but omits hypoglycemia warning signs, red-flag edema advice, and a definite re-evaluation timeframe.",
    "satisfaction": 50.0,
    "score": 10.0
  },
  {
    "rationale": "Little evidence-based discussion; no mention of sulfonylurea weight-gain risk, ARB guideline justification, or ADA lifestyle reinforcement beyond brief meal-plan note.",
    "satisfaction": 30.0,
    "score": 4.5
  },
  {
    "rationale": "Objective data largely absent\u2014no current weight, BP, glucose logs, edema description, or exact medication doses recorded.",
    "satisfaction": 25.0,
    "score": 2.5
  },
  {
    "rationale": "Documentation concise and encounter-focused with no redundant or irrelevant copy-paste material detected.",
    "satisfaction": 90.0,
    "score": 9.0
  }
]